Pharmacological Characterization of Novel Water-Soluble Cannabinoids

@article{Martin2006PharmacologicalCO,
  title={Pharmacological Characterization of Novel Water-Soluble Cannabinoids},
  author={Billy R. Martin and Jenny L. Wiley and Irina Beletskaya and L. J. Sim-Selley and Forrest L. Smith and William L. Dewey and Jean E. Cottney and Julia Adams and J Baker and David Zack Hill and Bijali Saha and Jonathan A. Zerkowski and A. P. Mahadevan and Raj Kumar Razdan},
  journal={Journal of Pharmacology and Experimental Therapeutics},
  year={2006},
  volume={318},
  pages={1230 - 1239}
}
  • B. MartinJ. Wiley R. Razdan
  • Published 1 September 2006
  • Chemistry, Biology
  • Journal of Pharmacology and Experimental Therapeutics
Presently, there are numerous structural classes of cannabinoid receptor agonists, all of which require solubilization for experimental purposes. One strategy for solubilizing water-insoluble tetrahydrocannabinols is conversion of the phenolic hydroxyl to a morpholinobutyryloxy substituent. The hydrochloride salts of these analogs are water-soluble and active in vivo when administered in saline. The present investigation demonstrated that hydrochloride salts of numerous substituted butyryloxy… 

Tables from this paper

Naturally occurring and related synthetic cannabinoids and their potential therapeutic applications.

This article reviews patents (2003-2007) that describe methods for isolation of cannabinoids from cannabis, chemical and chromatographic methods for their purification, synthesis, and potential therapeutic applications of these compounds.

Cannabinoid glycosides: In vitro production of a new class of cannabinoids with improved physicochemical properties

Increased aqueous solubility may enable new oral pharmaceutical delivery options for cannabinoids, as well as targeted delivery and release of cannabinoids within the intestines through glycoside prodrug metabolism.

The Structure–Function Relationships of Classical Cannabinoids: CB1/CB2 Modulation

This perspective will examine the classical cannabinoids, with particular emphasis on the structure–activity relationship of five regions: C3 side chain, phenolic hydroxyl, aromatic A-ring, pyran B- ring, and cyclohexenyl C-ring.

The Pharmacology of the Cannabinoid System—A Question of Efficacy and Selectivity

In this review, examples of the most commonly used receptor agonist, antagonists/inverse agonists, and indirectly acting agents (anandamide uptake inhibitors, fatty acid amide hydrolase inhibitors, monoacylglycerol lipase inhibitors) are given, with particular focus upon their selectivity and, in the case of the directly acting compounds, efficacy.

Synthetic cannabinoids (SC)

Pharmacological tools in endocannabinoid neurobiology.

  • M. MorA. Lodola
  • Biology, Chemistry
    Current topics in behavioral neurosciences
  • 2009
This chapter describes the main representatives of several classes of chemicals employed as pharmacological tools in this field, focusing on small organic compounds having, where possible, a drug-like structure.

Pharmacology and toxicology of the synthetic cannabinoid receptor agonists

These reports suggest that in addition to cannabis like neuropsychiatric effects the SCRAs are also associated with stimulant features (e.g., agitation, tachycardia, hypertension, seizures) and there are reports of SCRA-related ischaemic stroke, acute coronary syndrome, and acute kidney injury.

Medicinal Chemistry Endeavors around the Phytocannabinoids

This review summarizes past as well as recent developments in the structure–activity relationships of phytocannabinoids.

Pharmacology and Toxicology of the Synthetic Cannabinoid Receptor Agonists Pharmacologie et toxicologie des agonistes synthétiques des récepteurs cannabinoïdes

Reports suggest that in addition to cannabis like neuropsychiatric effects the SCRAs are also associated with stimulant features and there are reports of SCRA-related ischaemic stroke, acute coronary syndrome, and acute kidney injury.

References

SHOWING 1-10 OF 47 REFERENCES

Pharmacological evaluation of iodo and nitro analogs of Δ 8-THC and Δ 9-THC

Pharmacological evaluation of water soluble cannabinoids and related analogs.

Manipulation of the tetrahydrocannabinol side chain delineates agonists, partial agonists, and antagonists.

The finding that manipulations of the side chain produces high- affinity ligands with either antagonist, partial agonist, or full agonist effects reveals a critical structural feature for receptor activation.

Drugs derived from cannabinoids. 2. Basic esters of nitrogen and carbocyclic analogs.

It was shown that making the basic ester from the phenol retains biological activity and can lead to a greater selectivity of action, particularly the antinociceptive activity.

Potent cannabinergic indole analogues as radioiodinatable brain imaging agents for the CB1 cannabinoid receptor.

Radioiodinated 8 appears to be a suitable radioligand for studies of CB1 cannabinoid receptors.

Molecular probes for the cannabinoid receptors.

O‐1057, a potent water‐soluble cannabinoid receptor agonist with antinociceptive properties

The ability of the water‐soluble cannabinoid, O‐1057, to act as a potent agonist at CB1 and CB2 receptors is demonstrated and warrant investigation of the clinical potential of O‐ 1057 as an analgesic.

Potent cyano and carboxamido side-chain analogues of 1', 1'-dimethyl-delta8-tetrahydrocannabinol.

This study suggests that the incorporation of a cyano or an amide substituent in the side chain of Delta8-THC-DMH can enhance potency and can also lead to compounds with a unique profile which have high binding affinity and are practically devoid of agonist effects.

Anandamide prodrugs. 1. Water-soluble phosphate esters of arachidonylethanolamide and R-methanandamide.

  • J. JuntunenJ. Huuskonen T. Järvinen
  • Chemistry, Biology
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
  • 2003

Synthesis and structure-activity relationship of a novel series of aminoalkylindoles with potential for imaging the neuronal cannabinoid receptor by positron emission tomography.

A new series of CB(1) ligands with high binding affinity (K(i) = 0.7-100 nM) and moderate lipophilicity (cLogD(7.4)) in the range of 2.1-4.5 has been synthesized. A structure-activity relationship